Skip to content

Clinical trials

Inflammatory Breast Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Breast Neoplasms Country / region: Canada Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20072
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Hoffmann-La Roche1
NCIC Clinical Trials Group1
NSABP Foundation Inc1
National Cancer Institute (NCI)1
University Health Network, Toronto1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Breast Neoplasms7
Breast Neoplasms6
Breast Carcinoma In Situ1
Head and Neck Neoplasms1
Hypopharyngeal Neoplasms1
Laryngeal Neoplasms1
Mouth Neoplasms1
Nasopharyngeal Neoplasms1
Oropharyngeal Neoplasms1
Prostatic Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.